Embry Laboratories LLC

Embry Laboratories LLC was paid $1.85M by Medicaid between Sep 2021 and Apr 2023, across 2 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 100% of everything it billed.

33Billing provider infoEMBRY LABORATORIES LLC
TEMPE, AZ 85281

33aNPI1831780402assigned 01/27/2021

33bProvider typeClinical Medical Laboratory

28Total paid$1.85M

24GClaims23,819

24DCodes billed2

24AFirst – last monthSep 2021 – Apr 2023

Compared with peers

Next to other Clinical Medical Laboratory providers in Arizona

Rank by total paid#16 of 67

Median peer was paid$89K

This provider vs. median21×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Single-Code Concentration100% of spending on code U0003 with only 2 total codes billed. Highly concentrated billing profile.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	3,726	$287K
2022	19,460	$1.51M
2023	633	$49K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	100%	21,131	17,254	$1.85M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	2,688	2,193	$398.20

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialEMBRY, RAYMOND (OWNER)

Same official

Other billing entities under EMBRY, RAYMOND

Full network →

Provider	Location	Paid
Embry Testing and Vaccine Services of Arizona, LLC	Tempe, AZ	$52K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.